HOME >> BIOLOGY >> NEWS
JCI table of contents, December 1 2004

.org/press/15707.pdf">https://www.the-jci.org/press/15707.pdf

GLUT4 is at the center of a newly found mechanism of triglyceride production and utilization in type 2 diabetes

TITLE: GLUT4 glucose transporter deficiency increases hepatic lipid production and peripheral lipid utilization

AUTHOR CONTACT:
Barbara B. Kahn
Beth Israel Deaconess Medical Center
Boston, Massachusetts, USA
Phone: 617-667-5422
Fax: 617-667-2927
E-mail: bkahn@bidmc.harvard.edu.
View the PDF of this article at: https://www.the-jci.org/press/21341.pdf

ACCOMPANYING COMMENTARY:
TITLE: Metabolic fuel election: the importance of being flexible

AUTHOR CONTACT:
Perry E. Bickel
Washington University School of Medicine
St. Louis, Missouri, USA
Phone: 314-747-3979
Fax: 314-362-7641
E-mail: pbickel@im.wustl.edu.
View the PDF of this commentary at: https://www.the-jci.org/press/23745.pdf

Lack of fibrillin-1 may lead to faulty heart valves

TITLE: TGF-betadependent pathogenesis of mitral valve prolapse in a mouse model of Marfan syndrome

AUTHOR CONTACT:
Daniel P. Judge
Johns Hopkins University School of Medicine
Baltimore, Maryland, USA
Phone: 410-614-3085
Fax: 410-502-5336
E-mail: djudge@jhmi.edu.
View the PDF of this article at: https://www.the-jci.org/press/22715.pdf

ACCOMPANYING COMMENTARY:

TITLE: Marfan syndrome and mitral valve prolapse

AUTHOR CONTACT:
Arthur E. Weyman
Department of Medicine
Massachusetts General Hospital
Boston, Massachusetts, USA
P
'"/>

Contact: Brooke Grindlinger
press_releases@the-jci.org
212-342-0497
Journal of Clinical Investigation
1-Dec-2004


Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related biology news :

1. Antioxidant overload may underlie a heritable human disease
2. JCI table of contents: Aug. 9, 2007
3. JCI table of contents: August 1, 2007
4. US Department of Defense awards $1.6 million for implantable biochip research
5. More fish oil, less vegetable oil, better for your health
6. JCI table of contents -- July 26, 2007
7. JCI table of contents: July 19, 2007
8. JCI table of contents: July 12, 2007
9. JCI table of contents: June 21, 2007
10. JCI table of contents: June 14, 2007
11. Food safety begins as vegetables grow

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/3/2016)... , May 3, 2016  Neurotechnology, a ... the MegaMatcher Automated Biometric Identification System (ABIS) ... large-scale multi-biometric projects. MegaMatcher ABIS can process multiple ... using any combination of fingerprint, face or iris ... MegaMatcher SDK and MegaMatcher Accelerator , ...
(Date:4/28/2016)... and BANGALORE, India , April ... EdgeVerve Systems, a product subsidiary of Infosys (NYSE: ... today announced a global partnership that will provide ... to use mobile banking and payment services.      ... a key innovation area for financial services, but it also ...
(Date:4/28/2016)... , April 28, 2016 First quarter 2016: ... up 966% compared with the first quarter of 2015 ... SEK 589.1 M (loss: 18.8) and the operating margin was 40% ... 0.32) Cash flow from operations was SEK 249.9 M ... revenue guidance is unchanged, SEK 7,000-8,500 M. The operating ...
Breaking Biology News(10 mins):
(Date:5/4/2016)... ... May 05, 2016 , ... ... support the National Stroke Association during National Stroke Awareness Month in May. ... Twitter pages throughout the month. CereScan will donate $1 up to a ...
(Date:5/4/2016)... ... 04, 2016 , ... Looking for a gift to give ... cooking experience. Offering everything from gourmet cooking classes to weekend culinary adventures, LaJollaCooks4u ... Guests that visit LaJollaCooks4u share an experience unlike any other. Each class takes ...
(Date:5/4/2016)... ... 2016 , ... Proove Biosciences, Inc. , the commercial and research leader ... University . The partnership is designed to advance research in pain genetics in an ... pain. With the new agreement, researchers at Proove Biosciences are able to collaborate with ...
(Date:5/4/2016)...  Bayer today announced that a Phase III ... (regorafenib) tablets for the treatment of patients with ... endpoint of a statistically significant improvement in overall ... and safety of regorafenib in patients with HCC ... The safety and tolerability were generally consistent with ...
Breaking Biology Technology:
Cached News: